The Effects of Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neurological Function for Cerebral Infarction Patients in Convalescent Period
Latest Information Update: 24 Mar 2025
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary) ; Aspirin; Atorvastatin
- Indications Cerebral infarction
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
Most Recent Events
- 19 Mar 2025 Planned End Date changed from 31 Dec 2025 to 31 Dec 2026.
- 19 Mar 2025 Planned primary completion date changed from 30 Jun 2025 to 30 Jun 2026.
- 19 Mar 2025 Planned initiation date changed from 31 Dec 2024 to 31 Dec 2025.